Cancer Plus
Electronic ISSN: 2661-3840 Print ISSN: 2661-3832
Editors-in-Chief: Chong Li, Xiansheng Liu View Editorial Board

Cancer Plus is a research journal dedicated to the publication of findings in cancer research.  This journal is a joint collaboration between Shanxi Academy of Medical Sciences, Shanxi Bethune Hospital (China), and the Chinese Academy of Sciences.

We encourage researchers to publish the latest findings in cancer research, including preliminary results, repeated argumentation studies and negative results. The journal welcomes various types of submissions, e.g. research papers, clinical research reports, review articles.

ORIGINAL RESEARCH ARTICLE

Assessment of antibacterial, anti-inflammatory, and anti-cancer activities of Melia azedarach L. leaf extract

Mahendra Chikkamadaiah, Dwaraknath Venkatesha, Abhirami Dilkalal, Ravindra Kembalu Narayana, ... Satish Anandan
CP 2024, 6(1), 2763
ORIGINAL RESEARCH ARTICLE

Regulatory role of lncRNA MALAT1 and miR-150-3p interaction in breast cancer progression and therapeutic implications

Krishnamoorthy Vignesh, Pattusamy Thangamalar
CP 2024, 6(1), 2633
ORIGINAL RESEARCH ARTICLE

Cyclin-Dependent Kinase 8 (CDK8) Immunoexpression in Uveal Melanoma

Daniel M. Real, Edina A. Wappler-Guzzetta, Chelsea Huang, Aleksander M. Real, ... Justin C. Kerstetter
CP 2023, 5(4), 2608
ORIGINAL RESEARCH ARTICLE

Metastatic malignant Melanoma of the Maxillary Gingiva: A Case Report

B. Abdulhakeem, H. Boudhar, W. Bijou, Y. Oukessou, ... M. Mahtar
CP 2023, 5(4), 2594
Special Issues

Advances in Bone Metastasis Management

Guest Editor: Andrea Sambri
Submission deadline: 15 October 2024
News and Announcements
Share
Back to top
Cancer Plus, Electronic ISSN: 2661-3840 Print ISSN: 2661-3832, Published by AccScience Publishing